JINS HOLDINGS Inc. (JNDOF)
USD 22.75
(0.0%)
USD 22.75
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 23.07 Billion JPY | -32.74% |
| 2022 | 34.31 Billion JPY | 4.66% |
| 2021 | 32.78 Billion JPY | -7.97% |
| 2020 | 35.62 Billion JPY | 149.92% |
| 2019 | 14.25 Billion JPY | 20.92% |
| 2018 | 11.78 Billion JPY | -8.16% |
| 2017 | 12.83 Billion JPY | 16.77% |
| 2016 | 10.99 Billion JPY | 2.91% |
| 2015 | 10.68 Billion JPY | 27.62% |
| 2014 | 8.36 Billion JPY | -11.73% |
| 2013 | 9.48 Billion JPY | 33.78% |
| 2012 | 7.08 Billion JPY | 70.56% |
| 2011 | 4.15 Billion JPY | 85.96% |
| 2010 | 2.23 Billion JPY | 4.31% |
| 2009 | 2.14 Billion JPY | 58.65% |
| 2008 | 1.35 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 23.18 Billion JPY | 0.47% |
| 2024 Q3 | 24.71 Billion JPY | 3.71% |
| 2024 Q2 | 23.83 Billion JPY | 2.78% |
| 2023 Q2 | 21.67 Billion JPY | -35.19% |
| 2023 Q3 | 22.45 Billion JPY | 3.56% |
| 2023 Q4 | 23.07 Billion JPY | 2.8% |
| 2023 FY | 23.07 Billion JPY | -32.74% |
| 2023 Q1 | 33.45 Billion JPY | -2.52% |
| 2022 Q4 | 34.31 Billion JPY | 1.67% |
| 2022 FY | 34.31 Billion JPY | 4.66% |
| 2022 Q1 | 32.5 Billion JPY | -0.84% |
| 2022 Q3 | 33.74 Billion JPY | 2.38% |
| 2022 Q2 | 32.96 Billion JPY | 1.4% |
| 2021 Q3 | 32.37 Billion JPY | -4.56% |
| 2021 Q4 | 32.78 Billion JPY | 1.26% |
| 2021 Q1 | 33.63 Billion JPY | -5.58% |
| 2021 FY | 32.78 Billion JPY | -7.97% |
| 2021 Q2 | 33.92 Billion JPY | 0.85% |
| 2020 FY | 35.62 Billion JPY | 149.92% |
| 2020 Q1 | 13.09 Billion JPY | -8.1% |
| 2020 Q4 | 35.62 Billion JPY | 5.49% |
| 2020 Q3 | 33.77 Billion JPY | -14.06% |
| 2020 Q2 | 39.29 Billion JPY | 199.97% |
| 2019 Q2 | 11.67 Billion JPY | -14.24% |
| 2019 Q3 | 13.26 Billion JPY | 13.61% |
| 2019 Q4 | 14.25 Billion JPY | 7.46% |
| 2019 Q1 | 13.61 Billion JPY | 15.49% |
| 2019 FY | 14.25 Billion JPY | 20.92% |
| 2018 FY | 11.78 Billion JPY | -8.16% |
| 2018 Q2 | 11.9 Billion JPY | -14.6% |
| 2018 Q3 | 12.27 Billion JPY | 3.06% |
| 2018 Q4 | 11.78 Billion JPY | -3.96% |
| 2018 Q1 | 13.94 Billion JPY | 8.64% |
| 2017 Q4 | 12.83 Billion JPY | 5.33% |
| 2017 Q1 | 10.37 Billion JPY | -5.64% |
| 2017 Q2 | 11.64 Billion JPY | 12.22% |
| 2017 Q3 | 12.18 Billion JPY | 4.68% |
| 2017 FY | 12.83 Billion JPY | 16.77% |
| 2016 FY | 10.99 Billion JPY | 2.91% |
| 2016 Q4 | 10.99 Billion JPY | -1.33% |
| 2016 Q3 | 11.14 Billion JPY | -2.25% |
| 2016 Q2 | 11.39 Billion JPY | 4.45% |
| 2016 Q1 | 10.91 Billion JPY | 2.15% |
| 2015 Q1 | 8.74 Billion JPY | 4.52% |
| 2015 FY | 10.68 Billion JPY | 27.62% |
| 2015 Q2 | 8.88 Billion JPY | 1.53% |
| 2015 Q3 | 10.08 Billion JPY | 13.54% |
| 2015 Q4 | 10.68 Billion JPY | 5.92% |
| 2014 Q4 | 8.36 Billion JPY | 3.41% |
| 2014 FY | 8.36 Billion JPY | -11.73% |
| 2014 Q3 | 8.09 Billion JPY | 2.51% |
| 2014 Q2 | 7.89 Billion JPY | -8.62% |
| 2014 Q1 | 8.64 Billion JPY | -8.88% |
| 2013 Q2 | 9.14 Billion JPY | 25.07% |
| 2013 Q3 | 10.13 Billion JPY | 10.92% |
| 2013 Q4 | 9.48 Billion JPY | -6.47% |
| 2013 Q1 | 7.3 Billion JPY | 3.11% |
| 2013 FY | 9.48 Billion JPY | 33.78% |
| 2012 Q4 | 7.08 Billion JPY | 10.87% |
| 2012 Q2 | 5.12 Billion JPY | 12.29% |
| 2012 Q1 | 4.56 Billion JPY | 9.8% |
| 2012 Q3 | 6.39 Billion JPY | 24.78% |
| 2012 FY | 7.08 Billion JPY | 70.56% |
| 2011 FY | 4.15 Billion JPY | 85.96% |
| 2011 Q3 | 3.43 Billion JPY | 22.5% |
| 2011 Q4 | 4.15 Billion JPY | 20.94% |
| 2011 Q1 | 3.09 Billion JPY | 38.54% |
| 2011 Q2 | 2.8 Billion JPY | -9.39% |
| 2010 FY | 2.23 Billion JPY | 4.31% |
| 2010 Q4 | 2.23 Billion JPY | 11.8% |
| 2010 Q3 | 1.99 Billion JPY | 0.0% |
| 2009 Q4 | 2.14 Billion JPY | 0.0% |
| 2009 Q1 | 2.17 Billion JPY | 0.0% |
| 2009 Q2 | 2.45 Billion JPY | 13.09% |
| 2009 FY | 2.14 Billion JPY | 58.65% |
| 2008 FY | 1.35 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -982050.304% |
| Ansell Limited | 1.32 Billion USD | -1635.386% |
| Ansell Limited | 1.33 Billion USD | -1632.137% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -18167.699% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -2446855.592% |
| Psykey, Inc. | 2.47 Million USD | -932754.598% |
| ConvaTec Group Plc | 2.01 Billion USD | -1043.574% |
| ConvaTec Group Plc | 2.02 Billion USD | -1041.959% |
| Encision Inc. | 1.98 Million USD | -1163174.811% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -758958.03% |
| Innovative MedTech Inc. | 6.13 Million USD | -376095.446% |
| LifePoint, Inc. | 2.45 Million USD | -940299.785% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -226586.966% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -678694.118% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -758996.978% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -2972737.547% |
| SmileDirectClub, Inc. | 982.26 Million USD | -2249.579% |
| Sector 10, Inc. | 9.84 Million USD | -234313.374% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | -1602.36% |
| SheerVision, Inc. | 1.43 Million USD | -1612234.192% |
| United Health Products, Inc. | 1.99 Million USD | -1154502.928% |
| Vasamed, Inc. | 1 Million USD | -2295632.617% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -607196.558% |
| Yubo International Biotech Limited | 2.91 Million USD | -791924.775% |